Featured Research

from universities, journals, and other organizations

Lessons from epigenome evolution

Date:
June 11, 2012
Source:
Institute for Genomic Biology, University of Illinois at Urbana-Champaign
Summary:
The sequencing of the human genome has provided a wealth of genetic information, yet the goal of understanding the function of every gene remains outstanding. New research suggests determining the purpose of genes through a new method they call "comparative epigenomics."

The sequencing of the human genome has provided a wealth of genetic information, yet the goal of understanding the function of every gene remains outstanding. New research from the University of Illinois published in Cell suggests determining the purpose of genes through a new method they call "comparative epigenomics."

"Comparative epigenomics is to use interspecies comparison of DNA and histone modifications -- as an approach for annotation of the regulatory genome," says Sheng Zhong, of the Institute for Genomic Biology and Department of Bioengineering at the University of Illinois.

While the genome of an organism contains all its genes, it is the epigenome that decides which are expressed, or "turned on." Though genomic science has long focused on comparative genomics -- comparing the genomes of similar species and finding the commonalities to determine how common traits are regulated -- comparative epigenetics provides a more in-depth look at regulatory functions.

The researchers, led by Zhong, in collaboration with Ting Wang at Washington University, Harris Lewin, and Franklin West at University of Georgia, focused their work on three species: humans, mice, and pigs. By analyzing 9 epigenomic marks in pluripotent stem cells, they were able to create an epigenomic map for each which they could then compare.

The team concluded that, with proper analysis procedures, traces of interspecies epigenomic conservation could be identified. They then demonstrated that the conserved epigenetic markers can be effectively used to annotate the genome, clarifying the genome's regulatory function.

Understanding the genome is one of the most pressing problems for science, and this study sheds light on a promising alternative method. "Comparative epigenomics enables us to find more clues from evolution about the functions of our genomes," adds Shu Xiao, the first author of the paper.


Story Source:

The above story is based on materials provided by Institute for Genomic Biology, University of Illinois at Urbana-Champaign. Note: Materials may be edited for content and length.


Journal Reference:

  1. Shu Xiao, Dan Xie, Xiaoyi Cao, Pengfei Yu, Xiaoyun Xing, Chieh-Chun Chen, Meagan Musselman, Mingchao Xie, FranklinD. West, HarrisA. Lewin, Ting Wang, Sheng Zhong. Comparative Epigenomic Annotation of Regulatory DNA. Cell, 2012; 149 (6): 1381 DOI: 10.1016/j.cell.2012.04.029

Cite This Page:

Institute for Genomic Biology, University of Illinois at Urbana-Champaign. "Lessons from epigenome evolution." ScienceDaily. ScienceDaily, 11 June 2012. <www.sciencedaily.com/releases/2012/06/120611122636.htm>.
Institute for Genomic Biology, University of Illinois at Urbana-Champaign. (2012, June 11). Lessons from epigenome evolution. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2012/06/120611122636.htm
Institute for Genomic Biology, University of Illinois at Urbana-Champaign. "Lessons from epigenome evolution." ScienceDaily. www.sciencedaily.com/releases/2012/06/120611122636.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins